Period ended | Period ended | ||
3 May | 27 April | ||
2025 | 2024 | ||
£m | £m | ||
Continuing operations | |||
Revenue | 2, 3 | ||
Profit before interest and tax | |||
Finance income | |||
Finance costs | ( | ( | |
Net finance costs | 5 | ( | ( |
Profit before tax | |||
Income tax expense | 6 | ( | ( |
Profit after tax for the period from continuing operations | |||
Profit after tax for the period from discontinued operations | 22 | ||
Profit after tax for the period | |||
Earnings per share (pence) | 7 | ||
Basic – continuing operations | |||
Diluted – continuing operations | |||
Basic – total | |||
Diluted – total |
Period ended | Period ended | |||
3 May | 27 April | |||
2025 | 2024 | |||
Note | £m | £m | ||
Profit after tax for the period | ||||
Items that may be reclassified to the income statement in subsequent periods: | ||||
Cash flow hedges | ||||
Fair value movements recognised in other comprehensive income | 20 | ( | ||
Reclassified and reported in income statement | 20 | |||
Tax on movements on cash flow hedges | 6 | ( | ||
Gain/(loss) arising on translation of foreign operations | 20 | ( | ||
Reclassification of foreign currency translation differences due to disposal of foreign operations | 20 | ( | ||
( | ||||
Items that will not be reclassified to the income statement in subsequent periods: | ||||
Actuarial gain on defined benefit pension schemes | – UK | 19 | ||
– Overseas | 19 | |||
Tax on movements on defined benefit pension schemes | 6 | |||
Other comprehensive income for the period (taken to equity) | ||||
Total comprehensive income for the period – continuing operations | ||||
Total comprehensive income for the period – discontinued operations | ||||
Total comprehensive income for the period |
3 May | 27 April | ||
2025 | 2024 | ||
£m | £m | ||
Non-current assets | |||
Goodwill | 8 | ||
Intangible assets | 9 | ||
Property, plant & equipment | 10 | ||
Right-of-use assets | 11 | ||
Lease receivables | |||
Trade and other receivables | 13 | ||
Deferred tax assets | 6 | ||
Current assets | |||
Inventory | 12 | ||
Lease receivables | |||
Trade and other receivables | 13 | ||
Income tax receivable | |||
Derivative assets | 23 | ||
Cash and cash equivalents | 14 | ||
Total assets | |||
Current liabilities | |||
Trade and other payables | 15 | ( | ( |
Derivative liabilities | 23 | ( | ( |
Income tax payable | ( | ( | |
Loans and other borrowings | 16 | ( | ( |
Lease liabilities | 17 | ( | ( |
Provisions | 18 | ( | ( |
( | ( | ||
Non-current liabilities | |||
Trade and other payables | 15 | ( | ( |
Lease liabilities | 17 | ( | ( |
Retirement benefit obligations | 19 | ( | ( |
Deferred tax liabilities | 6 | ( | ( |
Provisions | 18 | ( | ( |
( | ( | ||
Total liabilities | ( | ( | |
Net assets | |||
Capital and reserves | |||
Share capital | 20 | ||
Share premium reserve | |||
Other reserves | 20 | ( | ( |
Accumulated profits | |||
Equity attributable to equity holders of the parent company |
Share | ||||||
Share | premium | Other | Accumulated | Total | ||
capital | reserve | reserves* | profits | equity | ||
Note | £m | £m | £m | £m | £m | |
At 29 April 2023 | ( | |||||
Profit for the period | ||||||
Other comprehensive (expense)/income recognised directly | ||||||
in equity | ( | |||||
Total comprehensive (expense)/income for the period | ( | |||||
Amounts transferred to the carrying value of inventory | ||||||
purchased during the period | ( | ( | ||||
Amounts transferred to accumulated profits | ( | |||||
Net movement in relation to share schemes | ( | |||||
Purchase of own shares – employee benefit trust | ( | ( | ||||
At 27 April 2024 | ( | |||||
Profit for the period | ||||||
Other comprehensive income recognised directly in equity | ||||||
Total comprehensive income for the period | ||||||
Amounts transferred to the carrying value of inventory | ||||||
purchased during the period | ( | ( | ||||
Net movement in relation to share schemes | 4 | |||||
Tax on items recognised directly in reserves | 6 | |||||
Purchase of own shares – employee benefit trust | 4 | ( | ( | |||
At | ( |
Period ended | Period ended | ||
3 May | 27 April | ||
2025 | 2024 | ||
Note | £m | £m | |
Operating activities | |||
Cash generated from operations | 24b | ||
Contributions to defined benefit pension scheme | 19 | ( | ( |
Income tax paid | ( | ( | |
Net cash flows from operating activities – continuing operations | |||
Net cash flows from operating activities – discontinued operations | ( | ||
Net cash flows from operating activities | |||
Investing activities | |||
Acquisition of property, plant & equipment and other intangibles | ( | ( | |
Net cash flows from investing activities – continuing operations | ( | ( | |
Net cash flows from investing activities – discontinued operations | ( | ||
Net cash flows from investing activities – discontinued operations: proceeds on sale of business | 24d | ( | |
Net cash flows from investing activities | ( | ||
Financing activities | |||
Interest paid | ( | ( | |
Capital repayment of lease liabilities | ( | ( | |
Purchase of own shares – employee benefit trust | ( | ( | |
Repayment of borrowings | ( | ||
Cash inflows/(outflows) from derivative financial instruments | ( | ||
Facility arrangement fees paid | ( | ( | |
Net cash flows from financing activities – continuing operations | ( | ( | |
Net cash flows from financing activities – discontinued operations | ( | ||
Net cash flows from financing activities | ( | ( | |
Increase in cash and cash equivalents and bank overdrafts | |||
Cash and cash equivalents and bank overdrafts at the beginning of the period | |||
Currency translation differences | ( | ||
Cash and cash equivalents and bank overdrafts at the end of the period | 24a |
Average | Closing | |||
2025 | 2024 | 2025 | 2024 | |
Euro | 1.19 | 1.16 | 1.17 | 1.17 |
Norwegian Krone | 13.89 | 13.42 | 13.82 | 13.78 |
Swedish Krona | 13.52 | 13.41 | 12.82 | 13.67 |
US Dollar | 1.28 | 1.26 | 1.33 | 1.25 |
Period ended 3 May 2025 | ||||
UK & Ireland | Nordics | Eliminations | Total | |
£m | £m | £m | £m | |
External revenue | 5,286 | 3,420 | – | 8,706 |
Inter-segmental revenue | 63 | – | (63) | – |
Total revenue | 5,349 | 3,420 | (63) | 8,706 |
Profit before interest and tax | 145 | 53 | – | 198 |
Finance income | 11 | |||
Finance costs | (85) | |||
Profit before tax on continuing operations | 124 | |||
Depreciation and amortisation | (164) | (125) | – | (289) |
Period ended 27 April 2024 | ||||
UK & Ireland | Nordics | Eliminations | Total | |
£m | £m | £m | £m | |
External revenue | 4,970 | 3,506 | – | 8,476 |
Inter-segmental revenue | 53 | – | (53) | – |
Total revenue | 5,023 | 3,506 | (53) | 8,476 |
Profit before interest and tax | 88 | 29 | – | 117 |
Finance income | 4 | |||
Finance costs | (93) | |||
Profit before tax on continuing operations | 28 | |||
Depreciation and amortisation | (163) | (136) | – | (299) |
Period ended 3 May 2025 | Period ended 27 April 2024 | |||||||||
UK | Norway | Sweden | Other | Total | UK | Norway | Sweden | Other | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Revenue | 5,092 | 1,010 | 1,129 | 1,475 | 8,706 | 4,784 | 1,039 | 1,140 | 1,513 | 8,476 |
Non-current assets | 1,915 | 445 | 463 | 542 | 3,365 | 1,992 | 449 | 399 | 587 | 3,427 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Revenue | 8,706 | 8,476 |
Cost of sales | (7,086) | (6,920) |
Gross profit | 1,620 | 1,556 |
Goodwill impairment | – | – |
Operating expenses | (1,422) | (1,439) |
Profit before interest and tax from continuing operations | 198 | 117 |
Period ended 3 May 2025 | |||
UK & Ireland | Nordics | Total | |
£m | £m | £m | |
Sale of goods | 4,541 | 3,117 | 7,658 |
Commission revenue | 173 | 161 | 334 |
Support services revenue | 231 | 47 | 278 |
Connectivity revenue | 202 | – | 202 |
Other services revenue | 139 | 95 | 234 |
Total revenue from continuing operations | 5,286 | 3,420 | 8,706 |
Period ended 27 April 2024 | |||
UK & Ireland | Nordics | Total | |
£m | £m | £m | |
Sale of goods | 4,296 | 3,208 | 7,504 |
Commission revenue | 178 | 165 | 343 |
Support services revenue | 229 | 43 | 272 |
Connectivity revenue | 134 | – | 134 |
Other services revenue | 133 | 90 | 223 |
Total revenue from continuing operations | 4,970 | 3,506 | 8,476 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Depreciation of property, plant & equipment | 39 | 41 |
Depreciation of right-of-use assets | 181 | 178 |
Impairment reversal of right-of-use assets | – | (1) |
Amortisation of acquisition intangibles | 23 | 23 |
Amortisation of other intangibles | 46 | 57 |
Impairment of other intangibles | – | 27 |
Impairment of inventory | 54 | 60 |
Gain on disposal from property, plant & equipment | (1) | – |
Cost of inventory recognised as an expense | 6,639 | 6,311 |
Cash flow hedge amounts reclassified and reported in income statement | 4 | 6 |
Net foreign exchange gains | – | (3) |
Share-based payments expense | 11 | 8 |
Other employee costs | 893 | 847 |
Restructuring costs* | 13 | 16 |
Regulatory (income)/costs* | (7) | 13 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Fees payable to the Company’s Auditor for the audit of the Company’s annual accounts | 0.1 | 0.1 |
Fees payable to the Company’s Auditor and its associates for the audit of the Company’s subsidiaries | 2.2 | 2.1 |
Total audit fees | 2.3 | 2.2 |
Audit-related assurance services: | ||
Review of interim statement | 0.2 | 0.2 |
Other assurance services | 0.2 | 0.8 |
Total audit and audit-related assurance services | 2.7 | 3.2 |
Total audit and non-audit fees | 2.7 | 3.2 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Salaries and performance bonuses | 756 | 724 |
Social security costs | 101 | 92 |
Other pension costs | 36 | 31 |
893 | 847 | |
Share-based payments | 11 | 8 |
904 | 855 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
number | number | |
UK & Ireland | 14,792 | 14,972 |
Nordics | 9,914 | 9,803 |
Greece | – | 3,003 |
27,778 |
Period ended 3 May 2025 | Period ended 27 April 2024 | |||
Board of | Executive | Board of | Executive | |
Directors | Committee | Directors | Committee | |
£m | £m | £m | £m | |
Short-term employee benefits | 4 | 5 | 4 | 4 |
Termination benefits | – | – | – | – |
Share-based payments | 2 | 2 | 1 | 2 |
6 | 7 | 5 | 6 |
Period ended 3 May 2025 | Period ended 27 April 2024 | |||
Number | WAEP | Number | WAEP | |
m | £ | m | £ | |
Outstanding at the beginning of the period | 88 | – | 82 | – |
Granted during the period | 30 | – | 36 | – |
Forfeited during the period | (18) | – | (20) | – |
Exercised during the period | (2) | – | (10) | – |
Outstanding at the end of the period | 98 | – | 88 | – |
Exercisable at the end of the period | 3 | – | 4 | – |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
Weighted average market price of options exercised in the period | £0.87 | £0.50 |
Weighted average remaining contractual life of awards outstanding | 8.1 yrs | 8.4 yrs |
Exercise price for options outstanding | £nil | £nil |
Period ended 3 May 2025 | Period ended 27 April 2024 | |||
Number | WAEP | Number | WAEP | |
m | £ | m | £ | |
Outstanding at the beginning of the period | 32 | 0.45 | 24 | 0.66 |
Granted during the period | 9 | 0.73 | 25 | 0.39 |
Exercised during the period | – | – | – | – |
Forfeited during period | (4) | 0.61 | (17) | 0.65 |
Outstanding at the end of the period | 37 | 0.50 | 32 | 0.45 |
Exercisable at the end of the period | – | 0.48 | – | 0.68 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
Weighted average market price of options exercised in the period | £0.85 | £nil |
Weighted average remaining contractual life of awards outstanding | 2.6 yrs | 3.2 yrs |
Range of exercise prices for options outstanding | £0.39 – £0.93 | £0.39 – £0.97 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
Exercise price | £nil – £0.73 | £nil – £0.39 |
Dividend yield | 0% – 2.9% | 0% – 2.5% |
Historical and expected volatility | 40% – 43% | 43% |
Expected option life | 4 – 10 yrs | 4 – 10 yrs |
Weighted average share price | £0.83 | £0.60 |
3 May 2025 | 27 April 2024 | |||||
Market | Nominal | Market | Nominal | |||
value | value | Number | value | value | Number | |
£m | £m | m | £m | £m | m | |
Investment in own shares | 68 | 0.1 | 59 | 26 | – | 42 |
Maximum number of shares held during the period | 51 | 0.1 | 59 | 20 | – | 43 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Unwind of discounts on trade and other receivables | 5 | 4 |
Other interest income | 6 | - |
Finance income | 11 | 4 |
Interest on bank overdrafts, loans and borrowings | (9) | (21) |
Interest expense on lease liabilities | (56) | (59) |
Net interest on defined benefit pension obligations | (8) | (11) |
Amortisation of facility fees | (4) | (2) |
Intercompany interest | – | (3) |
Other interest (expense)/income | (8) | 3 |
Finance costs | (85) | (93) |
Total net finance costs | (74) | (89) |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Current tax | ||
UK corporation tax at 25% (2023/24: 25%) | 11 | 7 |
Overseas tax | 6 | 5 |
17 | 12 | |
Adjustments made in respect of prior periods: | ||
UK corporation tax | – | (4) |
Overseas tax | – | (1) |
– | (5) | |
Total current tax | 17 | 7 |
Deferred tax | ||
UK corporation tax | (2) | (2) |
Overseas tax | 1 | (4) |
(1) | (6) | |
Adjustments in respect of prior periods: | ||
UK corporation tax | – | – |
Overseas tax | – | – |
– | – | |
Total deferred tax | (1) | (6) |
Total tax charge | 16 | 1 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Profit before taxation | 124 | 28 |
Tax at UK statutory rate of 25% (2023/24: 25%) | 31 | 7 |
Items attracting no tax relief or liability (i) | 1 | 2 |
Recognition of UK deferred tax asset (ii) | (2) | – |
Movement in unprovided deferred tax (iii) | (13) | (4) |
Differences in effective overseas tax rates | (1) | – |
Other tax adjustments | – | 1 |
Adjustments in respect of prior periods (iv) | – | (5) |
Total tax charge | 16 | 1 |
Accelerated | Retirement | Losses | Other | ||
capital | benefit | carried | temporary | ||
allowances | obligations | forward | differences | Total | |
£m | £m | £m | £m | £m | |
At 29 April 2023 | (26) | 6 | 11 | 17 | 8 |
Sale of Greece business | – | – | – | (4) | (4) |
(Charged)/credited directly to income statement | 5 | – | 1 | – | 6 |
(Charged) to equity | – | (1) | – | (1) | (2) |
At 27 April 2024 | (21) | 5 | 12 | 12 | 8 |
(Charged)/credited directly to income statement | – | – | (4) | 5 | 1 |
Credited to other comprehensive income | – | 17 | – | 2 | 19 |
Credited directly to equity | – | – | – | 4 | 4 |
At 3 May 2025 | (21) | 22 | 8 | 23 | 32 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Deferred tax assets | 148 | 127 |
Deferred tax liabilities | (116) | (119) |
32 | 8 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Defined benefit pension schemes | 17 | (1) |
Other temporary differences | 6 | (1) |
23 | (2) |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Profit for the period attributable to equity shareholders – continued operations | 108 | 27 |
Profit for the period attributable to equity shareholders – discontinued operations | – | 138 |
Profit for the period – total | 108 | 165 |
Million | Million | |
Weighted average number of shares | ||
Average shares in issue | 1,133 | 1,133 |
Less average holding by Group EBT shares held by Company | (52) | (27) |
For basic earnings per share | 1,081 | 1,106 |
Dilutive effect of share options and other incentive schemes | 51 | 22 |
For diluted earnings per share | 1,132 | 1,128 |
Pence | Pence | |
Earnings per share | ||
Basic earnings per share – continuing operations | 10.0 | 2.4 |
Diluted earnings per share – continuing operations | 9.5 | 2.4 |
Basic earnings per share – discontinued operations | – | 12.5 |
Diluted earnings per share – discontinued operations | – | 12.2 |
Basic earnings per share – total | 10.0 | 14.9 |
Diluted earnings per share – total | 9.5 | 14.6 |
Cost | £m |
At 29 April 2023 | 3,006 |
Foreign exchange | (33) |
At 27 April 2024 | 2,973 |
Foreign exchange | 14 |
At 3 May 2025 | 2,987 |
Accumulated impairment | £m |
At 29 April 2023 and 27 April 2024 | (736) |
Impairment | – |
At 3 May 2025 | (736) |
Carrying amount | £m |
At 29 April 2023 | 2,270 |
At 27 April 2024 | 2,237 |
At 3 May 2025 | 2,251 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
UK & Ireland | 1,329 | 1,329 |
Nordics | 922 | 908 |
2,251 | 2,237 |
3 May 2025 | 27 April 2024 | |||||||
Compound | Compound | Compound | Compound | |||||
annual | annual | Long-term | Pre-tax | annual | annual | Long-term | Pre-tax | |
growth in | growth in | growth | discount | growth in | growth in | growth | discount | |
sales | costs | rate | rate | sales | costs | rate | rate | |
UK & Ireland | 1.9% | 1.8% | 1.5% | 10.4% | 1.9% | 1.7% | 1.5% | 11.9% |
Nordics | 0.7% | 0.4% | 1.7% | 9.2% | 4.2% | 3.8% | 1.7% | 10.2% |
Acquisition intangibles | |||||
Customer | Software and | ||||
Brands | relationships | Sub-total | licences | Total | |
£m | £m | £m | £m | £m | |
Balance at 27 April 2024 | 115 | – | 115 | 131 | 246 |
Additions | – | – | – | 26 | 26 |
Amortisation | (23) | – | (23) | (46) | (69) |
Foreign exchange | 1 | – | 1 | – | 1 |
Balance at 3 May 2025 | 93 | – | 93 | 111 | 204 |
Cost | 367 | 73 | 440 | 500 | 940 |
Accumulated amortisation and impairment losses | (274) | (73) | (347) | (389) | (736) |
Balance at 3 May 2025 | 93 | – | 93 | 111 | 204 |
Included in net book value as at 3 May 2025 | |||||
Assets under construction | – | – | – | 7 | 7 |
Acquisition intangibles | |||||
Customer | Software and | ||||
Brands | relationships | Sub-total | licences | Total | |
£m | £m | £m | £m | £m | |
Balance at 29 April 2023 | 139 | – | 139 | 211 | 350 |
Additions | – | – | – | 23 | 23 |
Amortisation | (23) | – | (23) | (61) | (84) |
Disposed with subsidiary | – | – | – | (14) | (14) |
Impairment | – | – | – | (27) | (27) |
Foreign exchange | (1) | – | (1) | (1) | (2) |
Balance at 27 April 2024 | 115 | – | 115 | 131 | 246 |
Cost | 366 | 73 | 439 | 549 | 988 |
Accumulated amortisation and impairment losses | (251) | (73) | (324) | (41 8) | ( 742) |
Balance at 27 April 2024 | 115 | – | 115 | 131 | 246 |
Included in net book value as at 27 April 2024 | |||||
Assets under construction | – | – | – | 6 | 6 |
3 May 2025 | 27 April 2024 | |||
Remaining | Remaining | |||
amortisation | amortisation | |||
Net book value | period | Net book value | period | |
£m | Periods | £m | Periods | |
Currys | 48 | 5 | 60 | 6 |
Elgiganten | 21 | 5 | 25 | 6 |
Elkjøp | 13 | 5 | 16 | 6 |
Gigantti | 11 | 5 | 14 | 6 |
Fixtures, fittings | |||
Land and | and other | ||
buildings | equipment | Total | |
£m | £m | £m | |
Balance at 27 April 2024 | 43 | 68 | 111 |
Additions | 15 | 38 | 53 |
Disposals | – | (1) | (1) |
Depreciation | (11) | (28) | (39) |
Foreign exchange | – | 1 | 1 |
Balance as at 3 May 2025 | 47 | 78 | 125 |
Cost | 124 | 577 | 701 |
Accumulated depreciation | (77) | (499) | (576) |
Balance as at 3 May 2025 | 47 | 78 | 125 |
Included in net book value as at 3 May 2025 | |||
Assets under construction | – | 12 | 12 |
Fixtures, fittings | |||
Land and | and other | ||
buildings | equipment | Total | |
£m | £m | £m | |
Balance at 29 April 2023 | 62 | 93 | 155 |
Additions | 8 | 22 | 30 |
Disposals | (1) | (1) | (2) |
Depreciation | (13) | (33) | (46) |
Disposed with subsidiary | (12) | (11) | (23) |
Foreign exchange | (1) | (2) | (3) |
Balance as at 27 April 2024 | 43 | 68 | 111 |
Cost | 112 | 544 | 656 |
Accumulated depreciation | (69) | (476) | (545) |
Balance as at 27 April 2024 | 43 | 68 | 111 |
Included in net book value as at 27 April 2024 | |||
Assets under construction | – | 10 | 10 |
Land and | Vehicles and | ||
buildings | equipment | Total | |
£m | £m | £m | |
Balance at 27 April 2024 | 779 | 20 | 799 |
Additions | 145 | 3 | 148 |
Depreciation | (171) | (10) | (181) |
Disposals | (13) | – | (13) |
Foreign exchange | 8 | – | 8 |
Balance as at 3 May 2025 | 748 | 13 | 761 |
Cost | 1,513 | 64 | 1,577 |
Accumulated depreciation | (765) | (51) | (816) |
Balance as at 3 May 2025 | 748 | 13 | 761 |
Land and | Vehicles and | ||
buildings | equipment | Total | |
£m | £m | £m | |
Balance at 29 April 2023 | 967 | 28 | 995 |
Additions | 86 | 5 | 91 |
Depreciation | (182) | (11) | (193) |
Disposals | (6) | – | (6) |
Disposed with subsidiary | (70) | (2) | (72) |
Impairment reversal | 1 | – | 1 |
Foreign exchange | (17) | – | (17) |
Balance as at 27 April 2024 | 779 | 20 | 799 |
Cost | 1,433 | 62 | 1,495 |
Accumulated depreciation | (6 54) | (4 2) | (696) |
Balance as at 27 April 2024 | 779 | 20 | 799 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Finished goods and goods for resale | 1,037 | 1,034 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Trade receivables | 227 | 227 |
Less expected credit loss allowances | (22) | (22) |
205 | 205 | |
Contract assets | 38 | 58 |
Prepayments | 75 | 68 |
Other receivables | 27 | 17 |
Accrued income | 440 | 369 |
785 | 717 | |
Non-current | 100 | 101 |
Current | 685 | 616 |
785 | 717 |
3 May 2025 | 27 April 2024 | |||||
Expected | Expected | |||||
Gross trade | credit loss | Net trade | Gross trade | credit loss | Net trade | |
receivables | allowances | receivables | receivables | allowances | receivables | |
£m | £m | £m | £m | £m | £m | |
Ageing of gross trade receivables and expected credit loss allowances: | ||||||
Not yet due | 152 | (2) | 150 | 150 | (2) | 148 |
Past due: | ||||||
Under two months | 24 | (1) | 23 | 31 | (2) | 29 |
Two to four months | 8 | (1) | 7 | 13 | (2) | 11 |
Over four months | 43 | (18) | 25 | 33 | (16) | 17 |
75 | (20) | 55 | 77 | (20) | 57 | |
227 | (22) | 205 | 227 | (22) | 205 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Opening balance | (22) | (27) |
Charged to the income statement | (2) | (1) |
Receivables written off as irrecoverable | 1 | 5 |
Amounts recovered during the period | 1 | – |
Disposal of business | – | 1 |
Closing balance | (22) | (22) |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Insurance commission contract assets | 1 | 2 |
Network commission contract assets | 37 | 56 |
38 | 58 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Cash and cash equivalents | 209 | 125 |
3 May 2025 | 27 April 2024 | |||
Current | Non-current | Current | Non-current | |
£m | £m | £m | £m | |
Trade payables | 1,170 | 16 | 1,167 | 13 |
Other taxes and social security | 213 | – | 184 | – |
Other creditors | 2 | – | 1 | – |
Contract liabilities | 215 | 96 | 193 | 96 |
Accruals | 289 | 5 | 264 | 5 |
1,889 | 117 | 1,809 | 114 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Opening balance | 289 | 277 |
Revenue recognised in the period that was included in the opening balance | (176) | (147) |
Increase in contract liabilities in the period not yet recognised in revenue | 198 | 171 |
Disposed with subsidiary | – | (12) |
Closing balance | 311 | 289 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Current liabilities | ||
Bank overdrafts | 25 | 29 |
25 | 29 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Analysed as: | ||
Current | 201 | 202 |
Non-current | 739 | 801 |
940 | 1,003 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Amounts due: | ||
Year 1 | 234 | 250 |
Year 2 | 210 | 217 |
Year 3 | 175 | 190 |
Year 4 | 153 | 153 |
Year 5 | 116 | 131 |
Onwards | 251 | 275 |
1,139 | 1,216 |
3 May 2025 | |||||
Reorganisation | Sales | Property | Other | Total | |
£m | £m | £m | £m | £m | |
Balance at 27 April 2024 | 3 | 10 | 15 | 44 | 72 |
Additions | 4 | 26 | 5 | 9 | 44 |
Released in the period | (1) | – | (2) | (15) | (18) |
Utilised in the period | (2) | (26) | (4) | (10) | (42) |
Balance at 3 May 2025 | 4 | 10 | 14 | 28 | 56 |
Analysed as: | |||||
Current | 4 | 8 | 13 | 21 | 46 |
Non-current | – | 2 | 1 | 7 | 10 |
4 | 10 | 14 | 28 | 56 |
27 April 2024 | |||||
Reorganisation | Sales | Property | Other | Total | |
£m | £m | £m | £m | £m | |
Balance at 29 April 2023 | 7 | 10 | 27 | 4 | 48 |
Reclassifications (1) | – | – | – | 20 | 20 |
Additions | 8 | 25 | 5 | 27 | 65 |
Released in the period | (1) | – | (8) | (1) | (10) |
Utilised in the period | (11) | (25) | (9) | (6) | (51) |
Balance at 27 April 2024 | 3 | 10 | 15 | 44 | 72 |
Analysed as: | |||||
Current | 3 | 9 | 14 | 38 | 64 |
Non-current | – | 1 | 1 | 6 | 8 |
3 | 10 | 15 | 44 | 72 |
3 May | 27 April | ||
2025 | 2024 | ||
£m | £m | ||
Retirement benefit obligations | – UK | 102 | 170 |
– Nordics | 1 | 1 | |
103 | 171 |
Risk | Description | Mitigation |
Investment | The IAS 19 defined benefit obligations are calculated | The trustees regularly monitor the funding position and |
using a discount rate derived from the yield obtained | consider their long-term plan to implement a diversified | |
on high quality corporate bonds. If the pension | investment portfolio that generates sufficient returns whilst | |
scheme’s assets underperform relative to this discount | managing the investment risks posed to the scheme. | |
rate, the accounting deficit will increase. | ||
The Group regularly engages with the trustees on the | ||
If the underperformance of assets also results in a | scheme’s investment strategy and its management. | |
larger deficit for the funding valuation (carried out | ||
every 3 years as a minimum), the pension scheme | ||
may require additional contributions from the Group. | ||
Inflation | The IAS 19 defined benefit obligations are in part | As part of the investment strategy implemented by the |
linked to actual and future expected inflation. | trustees, inflation risk is mitigated through a liability-driven | |
Therefore, a higher rate of inflation will result in | investment (‘LDI’) portfolio. | |
a higher defined benefit obligation. | ||
The LDI portfolio consists of assets that increase/decrease | ||
A higher rate of inflation will also increase the | in value in line with inflation expectations. The scheme’s | |
Scheme’s funding liability, which may require | holding in LDI is designed to hedge a large amount of the | |
additional contributions from the Group, as a part | scheme’s funding liability and thereby mitigate the net | |
of discussions on the triennial funding valuation. | impact of any adverse movements in inflation expectations. | |
Interest rate | The IAS 19 defined benefit obligations are calculated | As part of the investment strategy implemented by the |
using a discount rate derived from the yields obtained | trustees, interest rate risk is mitigated through the investment | |
on corporate bonds of an appropriate duration. If | in a LDI portfolio. | |
long-term corporate bond yields reduce, the IAS 19 | ||
defined benefit obligations will increase. | The LDI portfolio consists of assets that increase/decrease | |
in value in line with interest rate movements. The scheme’s | ||
Similarly, a reduction in gilt yields (which are used | holding in LDI is designed to hedge a large amount of the | |
in part to calculate the liabilities for the funding | scheme’s funding liability and thereby mitigate the impact | |
valuation) will result in a higher funding liability, which | of any adverse movements in interest rates. | |
may require additional contributions from the Group, | ||
as a part of discussions on the triennial funding | However, as the LDI portfolio mitigates the interest rate risk | |
valuation. | on the funding basis, deviations between gilt and corporate | |
bond yields can lead to ineffective hedging in respect of the | ||
IAS 19 defined benefit obligations. The scheme’s credit asset | ||
allocation helps provide additional hedging in this area. | ||
Liquidity | The scheme is required to meet ongoing cash flows | The scheme operates a collateral adequacy framework |
requirements, including benefit payments to members | which ensures there are sufficient levels of liquid assets | |
and collateral calls on the scheme’s leveraged | to meet ongoing cash flows requirements, even in times of | |
investments. There is therefore a risk that the scheme | market distress. The framework is regularly assessed and | |
has insufficient liquid assets to meet these obligations. | appropriately managed to ensure it remains robust to | |
respond to significant market events. | ||
Longevity | The scheme provides pensions benefits for the duration | The trustees and the Group regularly monitor the outlook |
of a member’s life and typically to any surviving spouse. | for future life expectancy and the impact this might have | |
Therefore, an increase in life expectancy will result in | on the defined benefit obligations. | |
higher IAS 19 defined benefit obligations. | ||
Legislation | The scheme is exposed to the risk that new legislation | The trustees and the Group regularly monitor this and are |
or regulation could impact the valuation of the | kept up to date by their advisors on ongoing changes in | |
scheme’s liabilities in the future. | legislation and regulation, including the impact of these | |
to the scheme and the associated liabilities. |
3 May | 27 April | |
Rates per annum | 2025 | 2024 |
Discount rate | 5.70% | 5.20% |
Rate of increase in pensions in payment (pre/post April 2006 accrual) | 2.80%/1.95% | 3.00%/2.00% |
Rate of increase in deferred pensions (pre/post April 2006 accrual) | 2.90% | 3.15% |
Inflation | 2.90% | 3.15% |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Past service cost | – | – |
Net interest expense on defined benefit obligation | 8 | 11 |
Total expense recognised in the income statement | 8 | 11 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Remeasurement of defined benefit obligation – actuarial gains/(losses) arising from: | ||
Changes in demographic assumptions | – | 46 |
Changes in financial assumptions | 97 | 61 |
Experience adjustments | (2) | (4) |
Remeasurement of scheme assets: | ||
Actual return on plan assets (excluding amounts included in net interest expense) | (69) | (51) |
Cumulative actuarial gain | 26 | 52 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Present value of defined benefit obligations | (1,033) | (1,125) |
Fair value of plan assets | 931 | 955 |
Net obligation | (102) | (170) |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Opening obligation | 1,125 | 1,222 |
Past service cost | – | – |
Interest cost | 58 | 58 |
Remeasurements in other comprehensive income – actuarial (gains)/losses arising from changes in: | ||
Demographic assumptions | – | (4 6) |
Financial assumptions | (97) | (61) |
Experience adjustments | 2 | 4 |
Benefits paid | (55) | (52) |
Closing obligation | 1,033 | 1,125 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Opening fair value | 955 | 975 |
Interest income | 50 | 47 |
Employer contributions | 50 | 36 |
Remeasurements in other comprehensive income: | ||
Actual return on plan assets (excluding interest income) | (69) | (51) |
Benefits paid | (55) | (52) |
Closing fair value | 931 | 955 |
3 May | 27 April | ||
2025 | 2024 | ||
£m | £m | ||
Credit funds | – Listed | 194 | 164 |
– Unlisted | 210 | 228 | |
Private equity | – Unlisted | 1 | 2 |
Liability driven investments (‘LDIs’)* | – Listed | 808 | 681 |
– Unlisted | (396) | (253) | |
Synthetic equity* | – Unlisted | 83 | 117 |
Cash and cash instruments | – Unlisted | 31 | 15 |
Other | – Unlisted | – | 1 |
931 | 955 |
Net finance costs impact | Liability impact | |||
Period ended | Period ended | Period ended | Period ended | |
3 May | 27 April | 3 May | 27 April | |
2025 | 2024 | 2025 | 2024 | |
Positive/(negative) effect | £m | £m | £m | £m |
Discount rate: 1% increase | 8 | 7 | 135 | 150 |
Inflation rate: 1% increase* | (7) | (9) | (116) | (133) |
Life expectancy: 1-year increase | (2) | (2) | (42) | (4 5) |
3 May | 27 April | 3 May | 27 April | |
2025 | 2024 | 2025 | 2024 | |
million | million | £m | £m | |
Authorised, allotted, called-up and fully paid ordinary shares of 0.1p each | 1,133 | 1,133 | 1 | 1 |
3 May | 27 April | 3 May | 27 April | |
2025 | 2024 | 2025 | 2024 | |
million | million | £m | £m | |
Ordinary shares of 0.1p each in issue at the beginning and end | ||||
of the period | 1,133 | 1,133 | 1 | 1 |
Issued during the period | – | – | – | – |
Repurchased and cancelled during the period | – | – | – | – |
Ordinary shares of 0.1p each in issue at the beginning and end | ||||
of the period | 1,133 | 1,133 | 1 | 1 |
Investment in | |||||
Hedging | own shares | Translation | Demerger | ||
reserve | reserve | reserve | reserve | Total | |
£m | £m | £m | £m | £m | |
As at 29 April 2023 | (2) | (30) | (22) | (750) | (804) |
Other comprehensive income and expense recognised directly in equity | 9 | – | (41) | – | (32) |
Amounts transferred to the carrying value of inventory purchased during the period | (5) | – | – | – | (5) |
Amounts transferred to accumulated profits | – | 10 | (1) | – | 9 |
Purchase of own shares – EBT | – | (12) | – | – | (12) |
As at 27 April 2024 | 2 | (32) | (64) | (750) | (844) |
Other comprehensive income and expense recognised directly in equity | (4) | – | 17 | – | 13 |
Amounts transferred to the carrying value of inventory purchased during the period | (4) | – | – | – | (4) |
Amounts transferred to accumulated profits | – | 2 | – | – | 2 |
Purchase of own shares – EBT | – | (15) | – | – | (15) |
As at 3 May 2025 | (6) | (45) | (47) | (750) | (848) |
£m | |
Final dividend for the period ended 3 May 2025 of | 16 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Revenue | – | 579 |
Expenses | – | (577) |
Profit before tax | – | 2 |
Income tax expense | – | (2) |
Profit after income tax of discontinued operations | – | – |
Gain on sale of the subsidiary after income tax | – | 138 |
Profit for the period from discontinued operations | – | 138 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Lease receivables (3) | 3 | 4 |
Cash and cash equivalents (1) | 209 | 125 |
Trade and other receivables (1) | 672 | 591 |
Derivative financial assets (2) | 5 | 13 |
Derivative financial liabilities (2) | (16) | (4) |
Trade and other payables (1) | (1,345) | (1,327) |
Loans and other borrowings (1) | (25) | (29) |
Lease liabilities (3) | (940) | (1,003) |
3 May 2025 | |||||
Gross amounts | |||||
of recognised | Net amounts of | ||||
financial | financial assets | Financial | |||
Gross amounts | liabilities | presented in | instruments not | ||
of recognised | set off in the | the balance | set off in the | ||
financial assets | balance sheet | sheet | balance sheet | Net amount | |
£m | £m | £m | £m | £m | |
Forward foreign exchange contracts* | 5 | – | 5 | (4) | 1 |
5 | – | 5 | (4) | 1 |
27 April 2024 | |||||
Gross amounts | |||||
of recognised | Net amounts of | ||||
financial | financial assets | Financial | |||
Gross amounts | liabilities | presented in | instruments not | ||
of recognised | set off in the | the balance | set off in the | ||
financial assets | balance sheet | sheet | balance sheet | Net amount | |
£m | £m | £m | £m | £m | |
Forward foreign exchange contracts* | 13 | – | 13 | (4) | 9 |
13 | – | 13 | (4) | 9 |
3 May 2025 | |||||
Net amounts | |||||
Gross amounts | of financial | ||||
Gross amounts | of recognised | liabilities | Financial | ||
of recognised | financial assets | presented in | instruments not | ||
financial | set off in the | the balance | set off in the | ||
liabilities | balance sheet | sheet | balance sheet | Net amount | |
£m | £m | £m | £m | £m | |
Forward foreign exchange contracts* | (16) | – | (16) | 4 | (12) |
(16) | – | (16) | 4 | (12) |
27 April 2024 | |||||
Gross amounts | Net amounts | ||||
Gross amounts | of recognised | of financial | Financial | ||
of recognised | financial assets | liabilities | instruments not | ||
financial | set off in the | presented in the | set off in the | ||
liabilities | balance sheet | balance sheet | balance sheet | Net amount | |
£m | £m | £m | £m | £m | |
Forward foreign exchange contracts* | (4) | – | (4) | 4 | – |
(4) | – | (4) | 4 | – |
Period ended 3 May 2025 | Period ended 27 April 2024 | |||
Effect on profit | Effect on total | Effect on profit | Effect on total | |
before tax* | equity | before tax* | equity | |
£m | £m | £m | £m | |
10% movement in the US Dollar exchange rate | – | 7 | – | 7 |
10% movement in the Euro exchange rate | – | 21 | – | 23 |
10% movement in the Norwegian Krone exchange rate | – | 10 | – | 12 |
10% movement in the Swedish Krona exchange rate | – | 14 | – | 12 |
10% movement in the Danish Krone exchange rate | – | 9 | – | 8 |
10% movement in the Chinese Yuan Offshore exchange rate | – | 6 | – | 5 |
– | – |
3 May 2025 | ||||
In more than | ||||
one year but | ||||
not more than | In more than | |||
Within one year | five years | five years | Total | |
£m | £m | £m | £m | |
Lease liabilities | (234) | (653) | (253) | (1,140) |
Derivative financial instruments – gross cash outflows: | ||||
Forward foreign exchange contracts | (1,498) | – | – | (1,498) |
Derivative financial instruments – gross cash inflows: | ||||
Forward foreign exchange contracts | 1,487 | – | – | 1,487 |
Loans and other borrowings | (25) | – | – | (25) |
Trade and other payables | (1,329) | (16) | – | (1,345) |
(1,599) | (669) | (253) | (2,521) |
27 April 2024 | ||||
In more than | ||||
one year but | ||||
not more than | In more than | |||
Within one year | five years | five years | Total | |
£m | £m | £m | £m | |
Lease liabilities | (250) | (691) | (275) | (1,216) |
Derivative financial instruments – gross cash outflows: | ||||
Forward foreign exchange contracts | (1,474) | – | – | (1 ,474) |
Derivative financial instruments – gross cash inflows: | ||||
Forward foreign exchange contracts | 1,484 | – | – | 1,484 |
Loans and other borrowings | (29) | – | – | (29) |
Trade and other payables | (1,314) | (13) | – | (1,327) |
(1,583) | (704) | (275) | (2,562) |
3 May | 27 April | |
2025 | 2024 | |
Counterparty credit rating | £m | £m |
AAA to AA- | 157 | 82 |
A+ to A- | 49 | 41 |
BBB+ to BBB- | 3 | 2 |
209 | 125 |
3 May 2025 | 27 April 2024 | |||
Gross carrying | Expected | Gross carrying | Expected | |
amount | credit loss | Amount | credit loss | |
£m | £m | £m | £m | |
UK & Ireland – Business to Business | 4 | 2 | 5 | 3 |
UK & Ireland – Main Sales Ledger | 145 | 12 | 72 | 14 |
UK & Ireland – iD Mobile | 256 | 26 | 210 | 24 |
Nordics – Business to Business | 28 | 2 | 22 | 1 |
Nordics – Franchise Debtors | 33 | 3 | 29 | 2 |
Nordics – Main sales ledger | 30 | 3 | 46 | 2 |
496 | 48 | 384 | 46 |
3 May | 27 April | |
2025 | 2024 | |
Gross amounts of recognised financial assets | £m | £m |
Not yet due | 371 | 304 |
0 – 90 days | 77 | 44 |
91 – 180 days | 12 | 18 |
180+ days | 36 | 18 |
496 | 384 |
Period ended 3 May 2025 | Period ended 27 April 2024 | |||||
Change in fair | Change in fair | |||||
value used | value used | |||||
Maturing | to calculate | Maturing | to calculate | |||
hedges in the | Weighted | hedge | hedges in the | Weighted | hedge | |
next 12 months | average | ineffectiveness | next 12 months | average | ineffectiveness | |
£m | hedge rate | £m | £m | hedge rate | £m | |
Hedging USD purchases into GBP (UK) | 37 | 1.2804 | (1) | 48 | 1.2636 | – |
Hedging EUR purchases into GBP (UK) | 20 | 1.1729 | – | 27 | 1.1516 | – |
Hedging CNY purchases into GBP (UK) | 77 | 9.1215 | (3) | 63 | 8.9378 | – |
Hedging EUR purchases into NOK (Nordics) | 300 | 11.7048 | 3 | 306 | 11.5477 | 7 |
Hedging USD purchases into NOK (Nordics) | 47 | 10.9885 | (2) | 46 | 10.6233 | 2 |
Hedging SEK sales into NOK (Nordics) | 151 | 0.9574 | (5) | 133 | 0.9812 | 1 |
Hedging DKK sales into NOK (Nordics) | 97 | 0.6382 | (1) | 90 | 0.6455 | (2) |
Hedging GBP purchases into EUR (Ireland) | 83 | 1.1717 | – | 77 | 1.1517 | 1 |
812 | (9) | 790 | 9 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Cash at bank and on deposit | 209 | 125 |
Bank overdrafts | (25) | (29) |
Cash and cash equivalents and bank overdrafts at end of the period | 184 | 96 |
Period ended | Period ended | |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Profit after tax for the period | 108 | 27 |
Income tax expense | 16 | 1 |
Net finance costs | 74 | 89 |
Profit before interest and tax | 198 | 117 |
Depreciation and amortisation | 289 | 299 |
Share-based payment charge | 15 | 8 |
Loss on disposal of fixed assets | (1) | – |
Impairments and other non-cash items | 5 | 28 |
Operating cash flows before movements in working capital | 506 | 452 |
Movements in working capital: | ||
(Increase)/Decrease in inventory | (2) | (4 3) |
(Increase)/Decrease in receivables | (65) | (36) |
Increase/(Decrease) in payables | 84 | 21 |
(Decrease)/Increase in provisions | (16) | 25 |
1 | (33) | |
Cash generated from continuing operations | 507 | 419 |
Lease | ||||||
additions, | ||||||
27 April | Financing cash | modifications | Foreign | 3 May | ||
2024 | flows | and disposals | exchange | Interest | 2025 | |
£m | £m | £m | £m | £m | £m | |
Loans and other borrowings (note 16) | – | 9 | – | – | (9) | – |
Lease liabilities (note 17) (i) | (1,003) | 262 | (135) | (8) | (56) | (940) |
Total liabilities from financing activities (ii) | (1,003) | 271 | (135) | (8) | (65) | (940) |
Lease | ||||||
additions, | ||||||
29 April | Financing cash | modifications | Foreign | 27 April | ||
2023 | flows | and disposals | exchange | Interest | 2024 | |
£m | £m | £m | £m | £m | £m | |
Loans and other borrowings (note 16) | (178) | 197 | 4 | (1) | (22) | – |
Lease liabilities (note 17) (i) | (1,233) | 275 | 1 (iii) | 18 | (64) | (1,003) |
Total liabilities from financing activities (ii) | (1,411) | 472 | 5 | 17 | (86) | (1,003) |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Revenue from sale of goods and services | 14 | 14 |
Amounts owed to the Group | 1 | 1 |
3 May | 27 April | |
2025 | 2024 | |
£m | £m | |
Intangible assets | 1 | 1 |
Property, plant & equipment | – | 5 |
Contracted for but not provided for in the accounts | 1 | 6 |